551 related articles for article (PubMed ID: 7023829)
1. Pharmacokinetic and pharmacodynamic modeling in vivo.
Holford NH; Sheiner LB
Crit Rev Bioeng; 1981; 5(4):273-322. PubMed ID: 7023829
[TBL] [Abstract][Full Text] [Related]
2. Basic concepts of pharmacokinetic/pharmacodynamic (PK/PD) modelling.
Meibohm B; Derendorf H
Int J Clin Pharmacol Ther; 1997 Oct; 35(10):401-13. PubMed ID: 9352388
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetic-pharmacodynamic relationship.
Baggot JD
Ann Rech Vet; 1990; 21 Suppl 1():29S-40S. PubMed ID: 2080844
[TBL] [Abstract][Full Text] [Related]
4. Quantitative pharmacology or pharmacokinetic pharmacodynamic integration should be a vital component in integrative pharmacology.
Gabrielsson J; Green AR
J Pharmacol Exp Ther; 2009 Dec; 331(3):767-74. PubMed ID: 19779129
[TBL] [Abstract][Full Text] [Related]
5. The time course of drug effects.
Al-Sallami HS; Pavan Kumar VV; Landersdorfer CB; Bulitta JB; Duffull SB
Pharm Stat; 2009; 8(3):176-85. PubMed ID: 19626596
[TBL] [Abstract][Full Text] [Related]
6. Mechanism-based pharmacokinetic-pharmacodynamic (PK-PD) modeling in translational drug research.
Danhof M; de Lange EC; Della Pasqua OE; Ploeger BA; Voskuyl RA
Trends Pharmacol Sci; 2008 Apr; 29(4):186-91. PubMed ID: 18353445
[TBL] [Abstract][Full Text] [Related]
7. Effect of infusion rate on thiopental dose-response relationships. Assessment of a pharmacokinetic-pharmacodynamic model.
Gentry WB; Krejcie TC; Henthorn TK; Shanks CA; Howard KA; Gupta DK; Avram MJ
Anesthesiology; 1994 Aug; 81(2):316-24; discussion 25A. PubMed ID: 8053580
[TBL] [Abstract][Full Text] [Related]
8. Review on correlation between pharmacologic response and drug disposition.
Ritschel WA; Hussain A
Methods Find Exp Clin Pharmacol; 1984 Oct; 6(10):627-40. PubMed ID: 6392792
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetic/pharmacodynamic modeling in drug research and development.
Derendorf H; Lesko LJ; Chaikin P; Colburn WA; Lee P; Miller R; Powell R; Rhodes G; Stanski D; Venitz J
J Clin Pharmacol; 2000 Dec; 40(12 Pt 2):1399-418. PubMed ID: 11185661
[TBL] [Abstract][Full Text] [Related]
10. On setting the first dose in man: quantitating biotherapeutic drug-target binding through pharmacokinetic and pharmacodynamic models.
Lowe PJ; Tannenbaum S; Wu K; Lloyd P; Sims J
Basic Clin Pharmacol Toxicol; 2010 Mar; 106(3):195-209. PubMed ID: 20050847
[TBL] [Abstract][Full Text] [Related]
11. Relationship between pharmacokinetic half-life and pharmacodynamic half-life in effect-time modeling.
Keller F; Czock D; Zellner D; Giehl M
Int J Clin Pharmacol Ther; 1998 Mar; 36(3):168-75. PubMed ID: 9562234
[TBL] [Abstract][Full Text] [Related]
12. Drug therapy in childhood: what has been done and what has to be done?
Bartels H
Pediatr Pharmacol (New York); 1983; 3(3-4):131-43. PubMed ID: 6677868
[TBL] [Abstract][Full Text] [Related]
13. Considerations on pharmacodynamics and pharmacokinetics: can everything be explained by the extent of drug binding to its receptor?
Castañeda-Hernández G; Granados-Soto V
Can J Physiol Pharmacol; 2000 Mar; 78(3):199-207. PubMed ID: 10721811
[TBL] [Abstract][Full Text] [Related]
14. [Drug concentration-effect correlation].
Scheinin H
Duodecim; 1999; 115(20):2275-83. PubMed ID: 11973932
[No Abstract] [Full Text] [Related]
15. Integrated pharmacokinetic-dynamic modeling of drugs acting on the CNS.
Paalzow LK
Drug Metab Rev; 1984; 15(1-2):383-400. PubMed ID: 6378561
[TBL] [Abstract][Full Text] [Related]
16. The role of pharmacokinetic and pharmacokinetic/pharmacodynamic modeling in drug discovery and development.
Yu XQ; Wilson AG
Future Med Chem; 2010 Jun; 2(6):923-8. PubMed ID: 21426110
[No Abstract] [Full Text] [Related]
17. [Role of pharmacokinetic-pharmacodynamic relationships in drug development].
Bellissant E; Courcier-Duplantier S; Blin O;
Therapie; 2002; 57(4):347-57. PubMed ID: 12422555
[TBL] [Abstract][Full Text] [Related]
18. Development and application of physiologically based pharmacokinetic-modeling tools to support drug discovery.
Lüpfert C; Reichel A
Chem Biodivers; 2005 Nov; 2(11):1462-86. PubMed ID: 17191947
[TBL] [Abstract][Full Text] [Related]
19. Nociceptive stimulus modality-related difference in pharmacokinetic-pharmacodynamic modeling of morphine in the rat.
Shang GW; Liu DN; Yan LH; Cui XY; Zhang KP; Qi C; Chen J
Pharmacol Biochem Behav; 2006 Oct; 85(2):464-73. PubMed ID: 17126387
[TBL] [Abstract][Full Text] [Related]
20. [Model building in pharmacokinetics/Part II: Generalized theoretical presentation of complete integration of linear compartment models of optional structure (author's transl)].
Wolf M; Heinzel G; Koss FW; Bozler G
Arzneimittelforschung; 1977; 27(4a):900-4. PubMed ID: 577857
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
